1. Scrip
  2. >>Business
  3. >>Deals

Fearing Second Offer Failure, Stada Management Appeals To Shareholders

 
• By Sten Stovall

Stada's management is scared an offer from two private-equity suitors will fail a second time due to shareholder inactivity or reluctance to accept the deal before its Aug 16 deadline.

Clock
Stada Board Fears Time Is Running Out For Its Takeover • Source: Shutterstock

Racing against the clock, Stada Arzneimittel AG's executive board has voiced worry that the second takeover offer from two private equity suitors will also fail, leaving the German generics maker without a clear future.

With the deadline for acceptances just days away, Stada's leadership has issued an open letter imploring shareholders not to sit...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Spain’s SpliceBio Secures Sanofi and Roche Support In $135m Financing

 
• By Kevin Grogan

Series B cash will be used to advance its Stargardt disease gene therapy.

Insmed’s PAH Data Indicate Potential To Surpass Established Therapies

 
• By Joseph Haas

Insmed’s inhaled treprostinil exceeded goals for reducing pulmonary vascular resistance and improving six-minute walk test distance in Phase IIb data.

Stock Watch: On Q1 Vaccine Sales And Measles Outbreaks

 
• By Andy Smith

A recent study suggested that measles could become endemic in the US due to low vaccination rates. However, first-quarter vaccine sales offered a more nuanced picture.